Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

29.29USD
4:00pm EDT
Change (% chg)

$-0.70 (-2.33%)
Prev Close
$29.99
Open
$29.92
Day's High
$30.11
Day's Low
$29.01
Volume
36,299
Avg. Vol
75,091
52-wk High
$35.48
52-wk Low
$21.27

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 23.48 -0.759
Mar '18 8.32 -1.222
FY 2017 Dec '17 4.51 -1.643
Sep '17 4.28 -1.271
Jun '17 3.51 -1.269
Mar '17 3.09 -1.265
FY 2016 Dec '16 5.69 -1.357
Sep '16 19.08 -0.731
Jun '16 5.47 -1.063
Mar '16 18.41 -1.100
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 14.11 23.88 8.87 7.17
Quarter Ending Mar-19 2 15.46 21.50 9.43 --
Year Ending Dec-18 6 59.55 79.08 49.30 50.71
Year Ending Dec-19 6 80.76 105.00 44.99 69.12
Earnings (per share)
Quarter Ending Dec-18 6 -1.26 -1.11 -1.52 -1.07
Quarter Ending Mar-19 2 -1.13 -1.00 -1.26 --
Year Ending Dec-18 6 -4.38 -4.21 -4.70 -4.21
Year Ending Dec-19 6 -4.27 -3.72 -5.09 -4.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.75 32.14
P/E High - Last 5 Yrs. -- 41.76 46.82
P/E Low - Last 5 Yrs. -- 23.56 24.71
Beta 1.98 0.89 0.87
Price to Sales (TTM) 44.22 4.59 6.55
Price to Book (MRQ) 52.19 3.64 4.00
Price to Tangible Book (MRQ) 52.19 5.22 6.10
Price to Cash Flow (TTM) -- 20.18 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.82 1.68
Dividend Yield - 5 Year Avg -- 1.53 1.45
Dividend 5 Year Growth Rate -- -8.81 -5.91
Payout Ratio(TTM) -- 49.52 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 569.02 5.48 7.91
Sales (TTM) vs TTM 1 Yr. Ago 29.40 4.52 6.56
Sales - 5 Yr. Growth Rate -34.76 6.86 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 40.19 19.36 26.63
EPS (TTM) vs TTM 1 Yr. Ago -5.90 -- --
EPS - 5 Yr. Growth Rate -- 6.47 7.65
Capital Spending - 5 Yr. Growth Rate -1.46 7.62 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.95 2.22 2.22
Current Ratio (MRQ) 4.14 2.97 2.99
LT Debt to Equity (MRQ) 652.23 8.83 11.31
Total Debt to Equity (MRQ) 652.23 11.15 14.15
Interest Coverage (TTM) -37.91 40.44 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 91.43 55.18 54.36
Gross Margin - 5 Yr. Avg. -- 53.20 53.16
EBITD Margin (TTM) -606.62 -- --
EBITD - 5 Yr. Avg -843.35 18.67 16.13
Operating Margin (TTM) -635.34 12.80 3.36
Operating Margin - 5 Yr. Avg. -863.28 14.30 11.28
Pre-Tax Margin (TTM) -636.92 13.31 3.79
Pre-Tax Margin - 5 Yr. Avg. -864.29 14.69 11.54
Net Profit Margin (TTM) -639.90 9.92 0.60
Net Profit Margin - 5 Yr. Avg. -890.64 10.95 7.83
Effective Tax Rate (TTM) -- 20.78 20.73
Effective Tax Rate - 5 Yr. Avg. -- 23.93 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 119,368 833,339,537 725,680,242
Net Income/Employee (TTM) -763,835 96,510,060 84,001,075
Receivable Turnover (TTM) 5.81 5.04 5.06
Inventory Turnover (TTM) 0.23 2.55 3.65
Asset Turnover (TTM) 0.08 0.84 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -53.81 10.12 9.83
Return on Assets - 5 Yr. Avg. -68.58 11.43 10.94
Return on Investment (TTM) -63.76 13.18 12.83
Return on Investment - 5 Yr. Avg. -80.03 14.72 14.05
Return on Equity (TTM) -188.52 15.14 14.95
Return on Equity - 5 Yr. Avg. -114.29 15.90 15.39
  1 Year 3 Year 5 Year
Sales % -68.37 9.60 -34.76
EPS (TTM) % -27.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Theravance Biopharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 88.01%
# of Holders: 137
Total Shares Held: 48,494,741
3 Mo. Net Change: 186,696
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 11
# Reduced Positions: 3
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.